Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 249

1.

Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.

Hammond DA, Cullen J, Painter JT, McCain K, Clem OA, Brotherton AL, Chopra D, Meena N.

J Intensive Care Med. 2017 Jan 1:885066617725255. doi: 10.1177/0885066617725255. [Epub ahead of print]

PMID:
28820036
2.

Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.

Cullen J, Young D, Chen Y, Degon M, Farrell J, Sedarsky J, Baptiste W, Rosen P, Tolstikov V, Kiebish M, Kagan J, Srivastava S, Kuo HC, Moncur JT, Rosner IL, Narain N, Akmaev V, Petrovics G, Dobi A, McLeod DG, Srivastava S, Sesterhenn IA.

Eur Urol Focus. 2017 Mar 11. pii: S2405-4569(17)30064-0. doi: 10.1016/j.euf.2017.02.016. [Epub ahead of print]

PMID:
28753864
3.

Longitudinal regret after treatment for low- and intermediate-risk prostate cancer.

Hurwitz LM, Cullen J, Kim DJ, Elsamanoudi S, Hudak J, Colston M, Travis J, Kuo HC, Rice KR, Porter CR, Rosner IL.

Cancer. 2017 Jul 5. doi: 10.1002/cncr.30841. [Epub ahead of print]

PMID:
28678408
4.

Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.

Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N.

J Intensive Care Med. 2017 Jan 1:885066617714209. doi: 10.1177/0885066617714209. [Epub ahead of print]

PMID:
28618919
5.

Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer.

Hammerich KH, Donahue TF, Rosner IL, Cullen J, Kuo HC, Hurwitz L, Chen Y, Bernstein M, Coleman J, Danila DC, Metwalli AR.

Urol Oncol. 2017 Jul;35(7):460.e21-460.e28. doi: 10.1016/j.urolonc.2017.02.001. Epub 2017 Apr 11.

PMID:
28410987
6.
7.

A33 shows similar sensitivity to but is more specific than CDX2 as an immunomarker of colorectal carcinoma.

Wong NACS, Adamczyk LA, Evans S, Cullen J, Oniscu A, Oien KA.

Histopathology. 2017 Jul;71(1):34-41. doi: 10.1111/his.13194. Epub 2017 Apr 11.

PMID:
28226180
8.

Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.

Rastogi A, Ali A, Tan SH, Banerjee S, Chen Y, Cullen J, Xavier CP, Mohamed AA, Ravindranath L, Srivastav J, Young D, Sesterhenn IA, Kagan J, Srivastava S, McLeod DG, Rosner IL, Petrovics G, Dobi A, Srivastava S, Srinivasan A.

Genes Cancer. 2016 Nov;7(11-12):394-413. doi: 10.18632/genesandcancer.126.

9.

A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.

Banerji JS, Hurwitz LM, Cullen J, Wolff EM, Levie KE, Rosner IL, Brand TC, LʼEsperance JO, Sterbis JR, Porter CR.

Urol Oncol. 2017 May;35(5):234-242. doi: 10.1016/j.urolonc.2016.12.015. Epub 2017 Jan 19.

PMID:
28110975
10.

Image Gallery: Systemic sarcoidosis presenting within the black pigment of a cosmetic tattoo.

Flynn A, Molony P, Keeting C, Cullen J, Tobin AM.

Br J Dermatol. 2017 Jan;176(1):e2. doi: 10.1111/bjd.15047. No abstract available.

PMID:
28098390
11.

MAVS-dependent host species range and pathogenicity of human hepatitis A virus.

Hirai-Yuki A, Hensley L, McGivern DR, González-López O, Das A, Feng H, Sun L, Wilson JE, Hu F, Feng Z, Lovell W, Misumi I, Ting JP, Montgomery S, Cullen J, Whitmire JK, Lemon SM.

Science. 2016 Sep 30;353(6307):1541-1545. Epub 2016 Sep 15.

PMID:
27633528
12.

Respiratory syncytial virus outbreak on an adult stem cell transplant unit.

Kelly SG, Metzger K, Bolon MK, Silkaitis C, Mielnicki M, Cullen J, Rooney M, Blanke T, Tahboub A, Noskin GA, Zembower TR.

Am J Infect Control. 2016 Sep 1;44(9):1022-6. doi: 10.1016/j.ajic.2016.03.075. Epub 2016 Jul 15.

PMID:
27430734
13.

Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate Cancer.

Pham KN, Cullen J, Hurwitz LM, Wolff EM, Levie KE, Odem-Davis K, Banerji JS, Rosner IL, Brand TC, L'Esperance JO, Sterbis JR, Porter CR.

J Urol. 2016 Aug;196(2):392-8. doi: 10.1016/j.juro.2016.02.2972. Epub 2016 Mar 11.

PMID:
26976206
14.

Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.

Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll PR, Cullen J, Lawrence HJ.

Urology. 2016 Mar;89:69-75. doi: 10.1016/j.urology.2015.12.008. Epub 2015 Dec 23.

15.

A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic.

Hurwitz LM, Cullen J, Elsamanoudi S, Kim DJ, Hudak J, Colston M, Travis J, Kuo HC, Porter CR, Rosner IL.

Urol Oncol. 2016 May;34(5):233.e17-25. doi: 10.1016/j.urolonc.2015.11.014. Epub 2015 Dec 15.

PMID:
26705101
16.

A prospective, randomized, placebo-controlled trial of on-Demand vs. nightly sildenafil citrate as assessed by Rigiscan and the international index of erectile function.

Kim DJ, Hawksworth DJ, Hurwitz LM, Cullen J, Rosner IL, Lue TF, Dean RC.

Andrology. 2016 Jan;4(1):27-32. doi: 10.1111/andr.12118. Epub 2015 Dec 10.

17.

Association of Gallbladder Mucocele Histologic Diagnosis with Selected Drug Use in Dogs: A Matched Case-Control Study.

Gookin JL, Correa MT, Peters A, Malueg A, Mathews KG, Cullen J, Seiler G.

J Vet Intern Med. 2015 Nov-Dec;29(6):1464-72. doi: 10.1111/jvim.13649. Epub 2015 Oct 18.

18.

Excess Secretion of Gel-Forming Mucins and Associated Innate Defense Proteins with Defective Mucin Un-Packaging Underpin Gallbladder Mucocele Formation in Dogs.

Kesimer M, Cullen J, Cao R, Radicioni G, Mathews KG, Seiler G, Gookin JL.

PLoS One. 2015 Sep 28;10(9):e0138988. doi: 10.1371/journal.pone.0138988. eCollection 2015.

19.

Requirement for Transcription Factor Ets1 in B Cell Tolerance to Self-Antigens.

Russell L, John S, Cullen J, Luo W, Shlomchik MJ, Garrett-Sinha LA.

J Immunol. 2015 Oct 15;195(8):3574-83. doi: 10.4049/jimmunol.1500776. Epub 2015 Sep 9.

20.

Electron-Beam-Induced Deposition as a Technique for Analysis of Precursor Molecule Diffusion Barriers and Prefactors.

Cullen J, Lobo CJ, Ford MJ, Toth M.

ACS Appl Mater Interfaces. 2015 Sep 30;7(38):21408-15. doi: 10.1021/acsami.5b06341. Epub 2015 Sep 15.

PMID:
26340502

Supplemental Content

Loading ...
Support Center